XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid in Capital
Additional Paid in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                      
Beginning balance (in shares) at Dec. 31, 2021       28,095,000                
Beginning balance at Dec. 31, 2021 $ 504,345 $ (80,036) $ 424,309 $ 562 $ 640,937 $ (66,656) $ 574,281 $ (122,505) $ (13,380) $ (135,885) $ (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                       (1,181,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock upon the exercise of stock options (in shares)       96,000                
Issuance of common stock upon the exercise of stock options 813     $ 2 811              
Net issuance of restricted stock awards and restricted stock units (in shares)       88,000                
Net issuance of restricted stock awards and restricted stock units 1     $ 1                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                       (45,000)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (2,051)                     $ (2,051)
Stock-based compensation 3,536       3,536              
Foreign currency translation adjustments 512                   512  
Net loss (15,650)             (15,650)        
Ending balance (in shares) at Mar. 31, 2022       28,279,000                
Ending balance at Mar. 31, 2022 411,470     $ 565 578,628     (151,535)     (3,192) $ (12,996)
Treasury stock (in shares) at Mar. 31, 2022                       (1,226,000)
Beginning balance (in shares) at Dec. 31, 2021       28,095,000                
Beginning balance at Dec. 31, 2021 504,345 $ (80,036) $ 424,309 $ 562 640,937 $ (66,656) $ 574,281 (122,505) $ (13,380) $ (135,885) (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                       (1,181,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Foreign currency translation adjustments 351                      
Net loss (34,498)                      
Ending balance (in shares) at Jun. 30, 2022       28,331,000                
Ending balance at Jun. 30, 2022 395,500     $ 565 582,064     (170,383)     (3,353) $ (13,393)
Treasury stock (in shares) at Jun. 30, 2022                       (1,238,000)
Beginning balance (in shares) at Mar. 31, 2022       28,279,000                
Beginning balance at Mar. 31, 2022 411,470     $ 565 578,628     (151,535)     (3,192) $ (12,996)
Treasury stock (in shares) at Mar. 31, 2022                       (1,226,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock upon the exercise of stock options (in shares)       16,000                
Issuance of common stock upon the exercise of stock options 205       205              
Net issuance of restricted stock awards and restricted stock units (in shares)       36,000                
Net issuance of restricted stock awards and restricted stock units 0                      
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                       (12,000)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (397)                     $ (397)
Stock-based compensation 3,231       3,231              
Foreign currency translation adjustments (161)                   (161)  
Net loss (18,848)             (18,848)        
Ending balance (in shares) at Jun. 30, 2022       28,331,000                
Ending balance at Jun. 30, 2022 $ 395,500     $ 565 582,064     (170,383)     (3,353) $ (13,393)
Treasury stock (in shares) at Jun. 30, 2022                       (1,238,000)
Beginning balance (in shares) at Dec. 31, 2022 27,319,045     28,590,000                
Beginning balance at Dec. 31, 2022 $ 375,194     $ 570 595,286     (205,204)     (1,365) $ (14,093)
Treasury stock (in shares) at Dec. 31, 2022 (1,270,522)                     (1,271,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock upon the exercise of stock options (in shares)       5,000                
Issuance of common stock upon the exercise of stock options $ 52     $ 0 52              
Net issuance of restricted stock awards and restricted stock units (in shares)       160,000                
Net issuance of restricted stock awards and restricted stock units 2     $ 2                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                       (79,000)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (2,478)                     $ (2,478)
Stock-based compensation 3,055       3,055              
Foreign currency translation adjustments (42)                   (42)  
Net loss (15,905)             (15,905)        
Ending balance (in shares) at Mar. 31, 2023       28,755,000                
Ending balance at Mar. 31, 2023 $ 359,878     $ 572 598,393     (221,109)     (1,407) $ (16,571)
Treasury stock (in shares) at Mar. 31, 2023                       (1,350,000)
Beginning balance (in shares) at Dec. 31, 2022 27,319,045     28,590,000                
Beginning balance at Dec. 31, 2022 $ 375,194     $ 570 595,286     (205,204)     (1,365) $ (14,093)
Treasury stock (in shares) at Dec. 31, 2022 (1,270,522)                     (1,271,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock upon the exercise of stock options (in shares) 14,000                      
Foreign currency translation adjustments $ (1,559)                      
Net loss $ (35,607)                      
Ending balance (in shares) at Jun. 30, 2023 27,443,072     28,799,000                
Ending balance at Jun. 30, 2023 $ 342,216     $ 572 602,155     (240,811)     (2,924) $ (16,776)
Treasury stock (in shares) at Jun. 30, 2023 (1,356,277)                     (1,356,000)
Beginning balance (in shares) at Mar. 31, 2023       28,755,000                
Beginning balance at Mar. 31, 2023 $ 359,878     $ 572 598,393     (221,109)     (1,407) $ (16,571)
Treasury stock (in shares) at Mar. 31, 2023                       (1,350,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock upon the exercise of stock options (in shares)       9,000                
Issuance of common stock upon the exercise of stock options 147       147              
Net issuance of restricted stock awards and restricted stock units (in shares)       35,000                
Net issuance of restricted stock awards and restricted stock units 0     $ 0                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                       (6,000)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (205)                     $ (205)
Stock-based compensation 3,615       3,615              
Foreign currency translation adjustments (1,517)                   (1,517)  
Net loss $ (19,702)             (19,702)        
Ending balance (in shares) at Jun. 30, 2023 27,443,072     28,799,000                
Ending balance at Jun. 30, 2023 $ 342,216     $ 572 $ 602,155     $ (240,811)     $ (2,924) $ (16,776)
Treasury stock (in shares) at Jun. 30, 2023 (1,356,277)                     (1,356,000)